FDA Inspection 866229 — Aesica Pharmaceutical GmbH
The FDA completed an inspection of Aesica Pharmaceutical GmbH on January 17, 2014 in Monheim am Rhein. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- January 17, 2014
- Fiscal Year
- 2014
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Monheim am Rhein (Germany)